07/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/24/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing). The Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing) is authorized for use with oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/23/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/23/2020. This guidance is intended to aid school administrators as they consider how to protect the health, safety, and well-being of students, teachers, other school staff, their families, and communities, and prepare for educating students this fall, with key COVID-19 considerations listed. (Text)
07/23/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/23/2020. This web page provides guidance to K-12 schools on COVID-19 symptom screening as part of a school reopening process. The guidance detailed here is intended only for students in K-12 school settings. (Text)
07/23/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/23/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Helix COVID-19 Test that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/22/2020 12:00 AM EDT
Source: United Nations Development Programme (UNDP). Published: 7/22/2020. This database gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the COVID-19 pandemic. The goal is to ensure that laws protect the health and well-being of individuals and communities, and that they adhere to international human rights standards. It is a joint project of United Nations Development Programme (UNDP), World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS) and O’Neill Institute for National and Global Health Law at Georgetown University. (Text)
07/21/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/21/2020. This web page provides COVID-19 guidance and tools to help retirement communities make decisions, protect their residents and staff, and communicate with their communities. It includes social media messages, fact sheets, posters, and videos. (Text)
07/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QuantiVirus™ SARS-CoV-2 Multiplex Test Kit. The QuantiVirus™ SARS-CoV-2 Multiplex Test Kit is authorized for use with upper respiratory specimens and sputum collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/16/2020 12:00 AM EDT
Source: Greater New York Hospital Association. Published: 7/16/2020. This web page provides guidance and resources collected by the New York City Office of Chief Medical Examiner (OCME) and New York City Emergency Management to assist hospitals with mass fatality management during the COVID-19 pandemic. (Text)
07/01/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 7/2020. The steps in this two-page document provide a checklist that state and territorial health officials can begin following now to prepare for a successful program for COVID-19 vaccination. (PDF)
07/01/2020 12:00 AM EDT
Source: National Association of Community Health Centers (NACHC). Published: 7/2020. These frequently asked questions about COVID-19 and health centers will be updated periodically as new information becomes available. Topics include Infection Control/Personal Protective Equipment, Telehealth, and Temporary Sites. (Text)
07/01/2020 12:00 AM EDT
Source: Healthcare Ready. Published: 7/2020. This five-page document describes how your company can work with Healthcare Ready and its supply chain partners in providing supplies and resources to healthcare groups, community organizations, and patients as they cope with the effects of COVID-19 in their communities. (PDF)
07/01/2020 12:00 AM EDT
Source: Healthcare Ready. Published: 7/2020. This five-page document will help government officials assist community organizations, healthcare providers, and constituents in staying safe and healthy during this pandemic. The toolkit outlines how they can work with Healthcare Ready to procure personal protective equipment and medical supplies, provide assistance to constituents on navigating healthcare needs, and communicate critical messages to constituents. (PDF)
06/28/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/28/2020. Direct Service Providers (DSPs) include personal care attendants, direct support professionals, paraprofessionals, therapists, and others who provide a wide variety of home and community-based, health-related services that support people with disabilities. This web page, updated on June 28, 2020, provides guidance for DSPs for people with disabilities, and general guidance to protect themselves and their patients during the COVID-19 pandemic. (Text)
06/28/2020 12:00 AM EDT
Source: National Association of Community Health Centers (NACHC). Published: 6/28/2020. This one-page fact sheet is first in a series of tools for addressing social determinants of health (SDOH) during the COVID-19 pandemic, and outlines how Protocol for Responding to and Assessing Patients’ Assets, Risks, and Experiences (PRAPARE) SDOH domains impact individuals’ risk of morbidity and mortality from COVID-19. (PDF)
06/22/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 6/22/2020. The HHS Office for Civil Rights (OCR) has provided these Bulletins, Notifications of Enforcement Discretion, Guidance, and Resources that help explain how patient health information may be used and disclosed in response to the COVID-19 nationwide public health emergency, including under the Health Insurance Portability and Accountability Act (HIPAA). (Text)
05/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/27/2020. The CDC has provided COVID-19 guidance for group homes and direct service providers (DSPs) who provide assistance to people with disabilities. Many of the recommendations for COVID-19 preparation and response also apply to caregivers and DSPs for people with developmental and behavioral disorders, which are detailed on this web page. (Text)
05/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/19/2020. The CDC offers these considerations for ways in which schools can help protect students, teachers, administrators, and staff and slow the spread of COVID-19 if and when they reopen. Schools can determine, in collaboration with state and local health officials to the extent possible, whether and how to implement these considerations while adjusting to meet the unique needs and circumstances of the local community. (Text)
05/14/2020 12:00 AM EDT
Source: University of New Mexico (UNM). Published: 5/14/2020. This web page provides links to a webinar series about infection prevention and control (IPC) for COVID-19 in healthcare settings, hosted by the Centers for Disease Control and Prevention, World Health Organization, IPC professional societies, and Project ECHO. Topics are Triage of COVID-19 patients: Operational Considerations and Practical Examples; Healthcare facility readiness and monitoring; Healthcare worker risk assessment, monitoring, and other staff considerations; Assessing SARS-CoV-2 infection among healthcare workers and inpatients; Cleaning and disinfection in the context of COVID-19; WASH in healthcare settings in the context of COVID-19; Limiting the introduction of COVID-19 in healthcare settings; Rational use of personal protective equipment and emergency strategies; Advice on the use of medical and non-medical masks; IPC in nursing homes and long-term care settings; Considerations for SARI treatment centers; and Post-mortem considerations in context of COVID-19. (Video or Multimedia)
05/14/2020 12:00 AM EDT
Source: National Association of Community Health Centers (NACHC). Published: 5/14/2020. This eight-page memo provides considerations for health centers in determining the re-opening of dental services during the COVID-19 pandemic. A brief analysis of the Federal Tort Claims Act coverage, malpractice liability, CDC guidance, and applicable OSHA rules are provided. (PDF)
05/07/2020 12:00 AM EDT
Source: Federal Emergency Management Agency [Department of Homeland Security] (FEMA). Published: 5/7/2020. This three-page document provides a list of key findings and considerations for jurisdictions and communities across the country regarding alternate funeral arrangements during the COVID-19 pandemic. (PDF)
05/05/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 5/5/2020. This two-page guidance explains that even during the current COVID-19 public health emergency, covered health care providers are still required to obtain a valid Health Insurance Portability and Accountability Act (HIPAA) authorization from each patient whose protected health information will be accessible to the media before the media is given access to that protected health information. (PDF)
04/14/2020 12:00 AM EDT
Source: Federal Emergency Management Agency [Department of Homeland Security] (FEMA). Published: 4/14/2020. This four-page document provides a list of key findings and best practices as they relate to ongoing mass casualty management in COVID-19 operations across the country. (PDF)
04/13/2020 12:00 AM EDT
Source: Healthcare Ready. Published: 4/13/2020. This four-page FAQ document was created by Healthcare Ready in collaboration with the American Society of Health-System Pharmacists (ASHP) and the National Association of Chain Drug Stores (NACDS) to provide COVID-19 pandemic guidance and resources to pharmacies, pharmacists, and their patients on prescription medications. (PDF)
03/28/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 3/28/2020. In light of the Public Health Emergency concerning COVID-19, the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) is providing this six-page bulletin to ensure that entities covered by civil rights authorities keep in mind their obligations under laws and regulations that prohibit discrimination on the basis of race, color, national origin, disability, age, sex, and exercise of conscience and religion in HHS-funded programs. (PDF)
03/09/2020 12:00 AM EDT
Source: Washington State Department of Health. Published: 3/9/2020. This two-page document provides guidance for preventing infection in mortuary and funeral home workers who handle deceased persons with coronavirus disease 2019 (COVID-19), the illness caused by SARS-coronavirus-2 (SARS-CoV-2). (PDF)
02/17/2020 12:00 AM EST
Source: Royal College of Pathologists. Published: 2/17/2020. This 14-page guidance was produced to aid mortuary staff and pathologists in deciding if a post-mortem examination is appropriate on a possible COVID-19 death, and to advise them on the possible risks associated with such a case and how to reduce these risks. It also covers diagnosis of COVID-19 at post-mortem examination. (PDF)
.jpg)
No hay comentarios:
Publicar un comentario